A Comparison Between the Effects of Conventional Diets vs Intermittent Fasting Diabetic and Pre-diabetic Patients
Therapeutic Effects of Time Restricted Feeding and Calorie Restriction in Patients With Prediabetes and Diabetes
1 other identifier
interventional
128
1 country
1
Brief Summary
This research aims to find an effective dietary intervention among the Pakistani population. According to WHO, diabetes is on the rise in developing countries; the current prevalence among the Pakistani population is 11.2% which is expected to increase in the coming years which is in line with the similar documented trend in neighboring south Asian countries.3,11 Since, ethnic south Asians carry a greater risk for developing T2D at a younger age and along with the complications associated with diabetes due to its chronicity, this poses a significant threat and an increased disease burden on the health care system.11 This will be the first trial conducted on determining the efficacy of caloric restriction in a subset of Pakistani population. There is limited inconsistent data on the efficacy of time-restricted feeding, however, this will help elucidate if it does lead to positive effects on the bio-health markers. One of the major hurdles in caloric restriction is patient compliance, therefore, one of the intervention group will be used to determine if TRF with caloric restriction helps improve the patient's compliance and produces significant results. If such an intervention is effective in inducing weight loss it can also be applied for other overweight patients. Eventually, it will help in countering the rising obesity in the region. The ultimate purpose of the knowledge obtained is to find a patient friendly, novel and therapeutic dietary intervention which will help in limiting the rise in T2D patients. It'll help in introducing an effective lifestyle intervention to promote health, which will reduce the dependence on pharmacological therapies, as well as, in the long-term reduce burden on the health care system. The information obtained can provide framework for new guidelines in helping the patients to lose weight, which can be utilized by the government to increase general awareness which will help prevent diseases linked to obesity. In light of the randomized controlled trial, the primary health physicians can educate and increase awareness regarding the different dietary interventions the patients can utilize which will help increase the number of options for the patients. Social media platforms can be utilized due to their extended outreach for the transmission of accurate information to the general population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Sep 2020
Shorter than P25 for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 5, 2020
CompletedFirst Posted
Study publicly available on registry
July 9, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2021
CompletedJune 8, 2021
June 1, 2021
9 months
July 5, 2020
June 6, 2021
Conditions
Outcome Measures
Primary Outcomes (5)
Weight
Change in participants' weight.
12 weeks
FBS
Change in participants' fasting plasma glucose levels.
12 weeks
HbA1c
Change in percentage of glycated hemoglobin HbA1c in the participants' plasma.
12 weeks
OGTT
Change in participants' response to an oral glucose load.
12 weeks
Serum Lipid Profile.
Change in participant's serum lipid levels, including cholesterol, LDL, HDL and triglycerides.
12 weeks
Study Arms (4)
Calorie Restriction
EXPERIMENTALTime Restricted Feeding
EXPERIMENTALTime Restricted Feeding with Calorie Restriction
EXPERIMENTALControl
NO INTERVENTIONInterventions
Participants assigned to this arm to consume food at a caloric deficit of 500 calories per day.
Participants assigned to this arm to consume food at maintenance calories (calories required per day to maintain weight, calculated based on height, weight and physical activity using the MyFitnessPal application) within an 8-hour window during daylight hours.
Participants assigned to this arm to consume food at a caloric deficit of 500 calories per day within an 8-hour window during daylight hours.
Eligibility Criteria
You may qualify if:
- Glycemic values belonging to diabetes or prediabetes category.
- Weight stable for at least 6 months prior to start of study.
- Ability to understand English and use English language mobile applications.
You may not qualify if:
- Pregnant or breastfeeding women.
- Diabetics taking insulin or sulfonylureas.
- Smokers.
- History of cardiovascular disease.
- History of psychiatric or eating disorders.
- History of hypoglycemic episodes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Usman Bin Hameedlead
- World Health Organizationcollaborator
Study Sites (1)
The Aga Khan University Hospital
Karachi, Sindh, 74800, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Nadeem, M.B.B.S, M.D.
The Aga Khan University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 5, 2020
First Posted
July 9, 2020
Study Start
September 1, 2020
Primary Completion
May 15, 2021
Study Completion
May 15, 2021
Last Updated
June 8, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share